1. Home
  2. PURR vs RLYB Comparison

PURR vs RLYB Comparison

Compare PURR & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PURR

Hyperliquid Strategies Inc

N/A

Current Price

$3.26

Market Cap

24.9M

Sector

Health Care

ML Signal

N/A

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.69

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PURR
RLYB
Founded
2025
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.9M
24.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PURR
RLYB
Price
$3.26
$0.69
Analyst Decision
Strong Buy
Hold
Analyst Count
2
2
Target Price
$6.58
N/A
AVG Volume (30 Days)
1.5M
185.6K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$674,000.00
Revenue This Year
N/A
$17.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.71
52 Week Low
$3.15
$0.22
52 Week High
$4.65
$1.08

Technical Indicators

Market Signals
Indicator
PURR
RLYB
Relative Strength Index (RSI) N/A 49.41
Support Level N/A $0.71
Resistance Level N/A $0.80
Average True Range (ATR) 0.00 0.06
MACD 0.00 -0.00
Stochastic Oscillator 0.00 44.06

Price Performance

Historical Comparison
PURR
RLYB

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: